HOLLYWOOD, CALIFORNIA - JUNE 04: Jennifer Lawrence attends the premiere of 20th Century Fox's "Dark Phoenix" at TCL Chinese Theatre on June 04, 2019 in Hollywood, California. (Photo by Rich Fury/Getty Images)
Those fascinated by the saga of Elizabeth Holmes won’t be seeing beloved movie star Jennifer Lawrence attempt to replicate the Theranos founder’s signature deep voice or delve into her psyche, which led her to briefly become a Silicon Valley superstar before being prosecuted for defrauding her investors.
That’s because Lawrence has graciously backed out starring in a movie about Holmes’ spectacular rise and fall. She said that Amanda Seyfried did such a great job playing the notorious Stanford dropout in Hulu’s limited series, “The Dropout,” that she shouldn’t bother.
“I thought she was terrific,” Lawrence said, according to a tweet from New York Times reporter Kyle Buchanan, who recently interviewed the Academy Award winner. Lawrence was slated to produce the film, “Bad Blood,” which was to be directed by Adam McKay, based on the book, “Bad Blood: Secrets and Lies in a Silicon Valley Startup,” by Pulitzer Prize-winning investigative journalist John Carreyrou.
In complimenting Seyfried, Lawrence said, “I was like, ‘Yeah, we don’t need to redo that.’ She did it.”
Seyfried won acclaim and an Emmy for her portrayal of Holmes in “The Dropout.” The series was inspired by a popular ABC podcast of the same name that also recounted Holmes’ downfall.
For the role, Seyfried donned Holmes’ Steve Jobs-inspired black turtlenecks and pulled her blonde hair back into a messy bun. She also said at a Television Critics Association’s press event that she had to work “really hard” to develop the “signature deep voice,” the “odd” baritone that Holmes allegedly affected to convince investors and the public that she had the gravitas to be a Silicon Valley visionary.
Holmes famously dropped out of Stanford to start a company she claimed would revolutionize the healthcare industry by providing people with quick, low-cost, early detection of diseases and infection using a simple drop of blood.
The 38-year-old now awaits sentencing, scheduled for Nov. 18, after being convicted in January of defrauding investors out of more than $144 million. Theranos’ promised technology never worked, and jurors heard damning evidence that Holmes affixed pharmaceutical company logos to internal Theranos reports to falsely suggest the firms had validated the technology. Legal experts predict Holmes will receive a multi-year prison sentence for her crimes.
Meanwhile, Lawrence has been busy promoting her latest film, “Causeway,” which arrives on Apple Friday.
Originally published at Martha Ross